Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
0.176
0.00 (-0.06%)
At close: Nov 20, 2024, 4:00 PM
0.180
+0.004 (2.04%)
After-hours: Nov 20, 2024, 7:39 PM EST
Aclarion Revenue
Aclarion had revenue of $14.41K in the quarter ending September 30, 2024, a decrease of -24.43%. This brings the company's revenue in the last twelve months to $49.29K, down -41.41% year-over-year. In the year 2023, Aclarion had annual revenue of $75.40K with 24.75% growth.
Revenue (ttm)
$49.29K
Revenue Growth
-41.41%
P/S Ratio
21.28
Revenue / Employee
$8,215
Employees
6
Market Cap
1.79M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 75.40K | 14.96K | 24.75% |
Dec 31, 2022 | 60.44K | 152.00 | 0.25% |
Dec 31, 2021 | 60.29K | 11.64K | 23.93% |
Dec 31, 2020 | 48.65K | 21.76K | 80.88% |
Dec 31, 2019 | 26.90K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
iCoreConnect | 11.05M |
Akanda | 2.51M |
Tivic Health Systems | 957.00K |
60 Degrees Pharmaceuticals | 462.61K |
Sonnet BioTherapeutics Holdings | 55.88K |
ACON News
- 6 days ago - Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st - Accesswire
- 6 weeks ago - Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 7 weeks ago - Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - GlobeNewsWire
- 2 months ago - PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology - GlobeNewsWire
- 2 months ago - Aclarion Provides Corporate Update on Nociscan AI Technology Milestones - GlobeNewsWire
- 2 months ago - Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial - GlobeNewsWire
- 2 months ago - Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market - GlobeNewsWire
- 3 months ago - Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey - GlobeNewsWire